Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

197 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Quantitative impact of pre-analytical process on plasma uracil when testing for dihydropyrimidine dehydrogenase deficiency.
Maillard M, Launay M, Royer B, Guitton J, Gautier-Veyret E, Broutin S, Tron C, Le Louedec F, Ciccolini J, Richard D, Alarcan H, Haufroid V, Tafzi N, Schmitt A, Etienne-Grimaldi MC, Narjoz C, Thomas F; Groupe de Pharmacologie Clinique Oncologique (GPCO). Maillard M, et al. Among authors: guitton j. Br J Clin Pharmacol. 2023 Feb;89(2):762-772. doi: 10.1111/bcp.15536. Epub 2022 Oct 3. Br J Clin Pharmacol. 2023. PMID: 36104927 Free PMC article.
Therapeutic Drug Monitoring of Carboplatin in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors: Pharmacokinetic Results of a Phase II Multicenter Study.
Moeung S, Chevreau C, Broutin S, Guitton J, Lelièvre B, Ciccolini J, Massart C, Fléchon A, Delva R, Gravis G, Lotz JP, Bay JO, Gross-Goupil M, Paci A, Marsili S, Malard L, Chatelut E, Thomas F. Moeung S, et al. Among authors: guitton j. Clin Cancer Res. 2017 Dec 1;23(23):7171-7179. doi: 10.1158/1078-0432.CCR-17-1344. Epub 2017 Sep 19. Clin Cancer Res. 2017. PMID: 28928162 Clinical Trial.
Estimation of Unbound Carboplatin Clearance From Total Plasma Concentrations as a Means of Facilitating Therapeutic Drug Monitoring.
Moeung S, Chevreau C, Poinsignon V, Guitton J, Lelièvre B, Ciccolini J, Gladieff L, Massart C, Fléchon A, Delva R, Gravis G, Lotz JP, Bay JO, Gross-Goupil M, Delahousse J, Filleron T, Lochon I, Chatelut E, Thomas F. Moeung S, et al. Among authors: guitton j. Ther Drug Monit. 2019 Feb;41(1):66-74. doi: 10.1097/FTD.0000000000000569. Ther Drug Monit. 2019. PMID: 30299429
Multicentric phase II trial of TI-CE high-dose chemotherapy with therapeutic drug monitoring of carboplatin in patients with relapsed advanced germ cell tumors.
Chevreau C, Massard C, Flechon A, Delva R, Gravis G, Lotz JP, Bay JO, Gross-Goupil M, Fizazi K, Mourey L, Paci A, Guitton J, Thomas F, Lelièvre B, Ciccolini J, Moeung S, Gallois Y, Olivier P, Culine S, Filleron T, Chatelut E. Chevreau C, et al. Among authors: guitton j. Cancer Med. 2021 Apr;10(7):2250-2258. doi: 10.1002/cam4.3687. Epub 2021 Mar 5. Cancer Med. 2021. PMID: 33675184 Free PMC article. Clinical Trial.
Population pharmacokinetics of tenofovir in AIDS patients.
Gagnieu MC, Barkil ME, Livrozet JM, Cotte L, Miailhes P, Boibieux A, Guitton J, Tod M. Gagnieu MC, et al. Among authors: guitton j. J Clin Pharmacol. 2008 Nov;48(11):1282-8. doi: 10.1177/0091270008322908. Epub 2008 Sep 8. J Clin Pharmacol. 2008. PMID: 18779377
[Accreditation of the toxicological screening: recommendations of the SFBC-SFTA group].
Guitton J, Gaulier JM, Citterio-Quentin A, Abe E, Allibé N, Bartoli M, Cohen S, Monteil-Ganiere C, Garcia-Hejl C, Grosjean J, Richard D, Roman E, Saint-Marcoux F, Wendremaire M. Guitton J, et al. Ann Biol Clin (Paris). 2019 Apr 1;77(2):219-224. doi: 10.1684/abc.2019.1422. Ann Biol Clin (Paris). 2019. PMID: 30998200 Free article. French.
197 results